Recruitment rates and fear of phlebotomy in pediatric patients in a genetic study of epilepsy

被引:21
作者
Dlugos, DJ [1 ]
Scattergood, TM
Ferraro, TN
Berrettinni, WH
Buono, RJ
机构
[1] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA
关键词
epilepsy genetics; epilepsy susceptibility; informed consent; therapeutic drug monitoring;
D O I
10.1016/j.yebeh.2005.01.014
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study examined participation rates and reasons for refusal in a genetic study of human epilepsy. The study enrolled children with epilepsy and their parents, and required signing informed consent, verbalizing assent, and giving a peripheral blood sample. One hundred sixty-eight children met inclusion criteria; 137 agreed to enroll (82%), and 31 refused (18%). Sixteen of thirty-one patients (52%) who refused cited fear of phlebotomy as the reason for refusal. All patients refusing due to fear of phlebotomy did not require blood tests for clinical purposes. As fear of phlebotomy is the primary reason for study refusal, obtaining DNA samples from a buccal swab or mouthwash protocol may be an alternative for some studies, although there are limitations to these methods. Further analysis of the factors influencing decisions to decline study enrollment is warranted. These data will help in the design of future genetic studies and may increase future participation rates. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:444 / 446
页数:3
相关论文
共 7 条
[1]   Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility [J].
Buono, RJ ;
Lohoff, FW ;
Sander, T ;
Sperling, MR ;
O'Connor, MJ ;
Dlugos, DJ ;
Ryan, SG ;
Golden, GT ;
Zhao, H ;
Scattergood, TM ;
Berrettini, WH ;
Ferraro, TN .
EPILEPSY RESEARCH, 2004, 58 (2-3) :175-183
[2]   Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: Nomination of Kcnj10 as a causative gene [J].
Ferraro T.N. ;
Golden G.T. ;
Smith G.G. ;
Martin J.F. ;
Lohoff F.W. ;
Gieringer T.A. ;
Zamboni D. ;
Schwebel C.L. ;
Press D.M. ;
Kratzer S.O. ;
Zhao H. ;
Berrettini W.H. ;
Buono R.J. .
Mammalian Genome, 2004, 15 (4) :239-251
[3]   Mapping murine loci for seizure response to kainic acid [J].
Ferraro, TN ;
Golden, GT ;
Smith, GG ;
Schork, NJ ;
Jean, PS ;
Ballas, C ;
Choi, H ;
Berrettini, WH .
MAMMALIAN GENOME, 1997, 8 (03) :200-208
[4]   The use of whole genome amplification in the study of human disease [J].
Hughes, S ;
Arneson, N ;
Done, S ;
Squire, J .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2005, 88 (01) :173-189
[5]   Therapeutic drug monitoring of the newer antiepileptic drugs [J].
Johannessen, SI ;
Battino, D ;
Berry, DJ ;
Bialer, M ;
Krämer, G ;
Tomson, T ;
Patsalos, PN .
THERAPEUTIC DRUG MONITORING, 2003, 25 (03) :347-363
[6]   Genotyping accuracy for whole-genome amplification of DNA from buccal epithelial cells [J].
Leviel, K ;
Olarte, M ;
Sullivan, PF .
TWIN RESEARCH, 2004, 7 (05) :482-484
[7]   DNA banking for epidemiologic studies: A review of current practices [J].
Steinberg, K ;
Beck, J ;
Nickerson, D ;
Garcia-Closas, M ;
Gallagher, M ;
Caggana, M ;
Reid, Y ;
Cosentino, M ;
Ji, J ;
Johnson, D ;
Hayes, RB ;
Earley, M ;
Lorey, F ;
Hannon, H ;
Khoury, MJ ;
Sampson, E .
EPIDEMIOLOGY, 2002, 13 (03) :246-254